EUCTR2014-003873-41-NL
Active, not recruiting
Phase 1
on invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial - HX4 several disease
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MAASTRO Clinic
- Enrollment
- 100
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-Primary tumor site: prostate, esophagus, grade IV glioma or rectum
- •\- Metastastic disease to brain (originating from e.g., breast, lung or colorectal primary tumor)
- •\-WHO performance status 0 to 2
- •\- No chronic renal function failure or no renal dialysis
- •\- The patient is willing and capable to comply with study procedures
- •\- 18 years or older
- •\- Have given written informed consent before patient registration
- •\-Histological confirmed prostate tumor
- •\-High grade tumor (Gleason score \=8\)
- •\-Macroscopically visual tumor on MRI
Exclusion Criteria
- •\- Recent (\< 3 months) myocardial infarction
- •\- Pregnant or breast feeding and willing to take adequate contraceptive measures during the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
on invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trialhersenen, primaire maligne glioom of metastasencancer: several diseases1001799010038597NL-OMON44468MAASTRO Clinic120
Not yet recruiting
Phase 2
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PETNL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20
Completed
Not Applicable
PET With [18F]HX4 in Head and Neck CancerCancer of the Head and NeckNCT01347281Maastricht Radiation Oncology23
Terminated
Phase 2
PET CT With HX4 in Cervix CancerCervix CancerNCT02233387Maastricht Radiation Oncology4
Terminated
Phase 2
Tumor Hypoxia With HX4 PET in Several DiseasesProstatic NeoplasmsEsophageal NeoplasmsNeoplasm Metastases, BrainRectal NeoplasmsBrain Neoplasm, PrimaryNCT02584400Maastricht Radiation Oncology1